Issue Information
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan
Welcome to the ICD‐10 code for sarcopenia
Cachexia research in Japan
Exercise rehabilitation following intensive care unit discharge for recovery from critical illness
Eating‐related distress and need for nutritional support of families of advanced cancer patients
Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries
Skeletal muscle satellite cells are located at a closer proximity to capillaries in healthy young compared with older men
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Nutritional leucine supplementation attenuates cardiac failure in tumour‐bearing cachectic animals
Docosahexaenoic acid‐supplementation prior to fasting prevents muscle atrophy in mice
Expression of protocadherin gamma in skeletal muscle tissue is associated with age and muscle weakness
Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle
Abstracts of the 9th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Berlin, Germany, 10–11 December 2016 (part 1)